# Bioventus Inc.: Form 8-K, filed Oct 4, 2024

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2024-10-04
- Accepted by EDGAR: Oct 4, 2024, 07:45 ET
- Period: 2024-09-30
- Accession: 0001628280-24-042266
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000162828024042266/bvs-20240930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000162828024042266/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000162828024042266/bvs-20240930.htm

Filed Oct 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-042266. Last ingested by Listed: Nov 2, 2026, 17:44 ET. No prices; not investment advice.